Vivo Bio TechBOM:511509 +0.51%63 Gross Margin % is 83.33% as of Mar. 2026, which is 2% below its 10-year median of 84.65. GuruFocus rates BOM:511509 with a GF Score™ of 63/100 and a GF Value™ of ₹29.50 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 732 Biotechnology companies, Vivo Bio Tech ranks better than 77.19% on this metric.
The historical rank and industry rank for Vivo Bio Tech's Gross Margin % or its related term are showing as below:
BOM:511509'
s Gross Margin % Range Over the Past 10 Years
Min: 76.14 Med: 84.65 Max: 91.53
Current: 84.76
During the past 13 years, the highestGross Margin % of Vivo Bio Tech was 91.53%. The lowest was 76.14%. And the median was 84.65%.
BOM:511509's Gross Margin % is ranked better than 77.19% of 732
companies
in the Biotechnology industry
Industry Median: 60.91
vs BOM:511509: 84.76
Vivo Bio Tech had a gross margin of 83.33% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Vivo Bio Tech was 1.00% per year.
Vivo Bio Tech (BOM:511509) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Vivo Bio Tech had a gross margin of 83.33% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Vivo Bio Tech Gross Margin % Related Terms
Vivo Bio Tech Gross Margin % Historical Data
* Premium members only.
The historical data trend for Vivo Bio Tech's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:511509 vs VRTX, REGN, ALNY: Gross Margin % Comparison
For the Biotechnology subindustry, Vivo Bio Tech's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vivo Bio Tech Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Vivo Bio Tech's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Vivo Bio Tech's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Vivo Bio Tech (BOM:511509) has a Gross Margin % of 83.33% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Vivo Bio Tech and its competitors. This is near median its historical median of 84.65. Over the past decade, Vivo Bio Tech's Gross Margin % has ranged from 76.14 to 91.53. According to the industry distribution chart, Vivo Bio Tech ranks #167 out of 732 companies in the Biotechnology industry, placing it in the top 22.8%.
Is Vivo Bio Tech's Gross Margin % too high?
Vivo Bio Tech's current Gross Margin % of 83.33% is near median its 10-year median of 84.65. Over the past 10 years, this metric has ranged from a low of 76.14 to a high of 91.53. The Biotechnology industry median Gross Margin % is 60.91. Vivo Bio Tech's value of 83.33% is 36.8% above this industry median. Based on the distribution chart, Vivo Bio Tech ranks #167 out of 732 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Vivo Bio Tech has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vivo Bio Tech's Gross Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Vivo Bio Tech ranks #167 out of 732 companies for Gross Margin %. This places Vivo Bio Tech in the top 23% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 60.91. Vivo Bio Tech's value of 83.33% is 36.8% above this benchmark. Historically, Vivo Bio Tech's own Gross Margin % has ranged from 76.14 to 91.53 over the past decade. While the company's 10-year median is 84.65 vs. the industry median of 60.91, Vivo Bio Tech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.91, based on 732 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vivo Bio Tech's current Gross Margin % of 83.33% is 36.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Vivo Bio Tech and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vivo Bio Tech's current Gross Margin % is 83.33%, which is near median its own 10-year median of 84.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vivo Bio Tech stock overvalued right now?
Based on GuruFocus' analysis, Vivo Bio Tech (BOM:511509) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹29.50, compared to a current price of ₹23.62 — trading 19.9% below its estimated fair value. The current Gross Margin % is 83.33%, which is near median its 10-year median of 84.65 and 36.8% above the Biotechnology industry median of 60.91. Vivo Bio Tech's overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Vivo Bio Tech (BOM:511509), the current Gross Margin % is 83.33% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vivo Bio Tech (BOM:511509) Overvalued in 2026?
Based on GuruFocus' analysis, Vivo Bio Tech stock appears to be undervalued.
The current stock price of ₹23.62 is trading 19.9% below its estimated GF Value™ of ₹29.50.
GuruFocus considers Vivo Bio Tech to be Modestly Undervalued.
Key valuation signals for BOM:511509:
Gross Margin %: 83.33% (near median its 10-year median of 84.65)
GF Value™: ₹29.50 vs. price of ₹23.62 (19.9% below fair value)
Industry Position: 36.8% above the Biotechnology median (#167 of 732)
No single metric tells the full story. See the BOM:511509 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vivo Bio Tech Ltd offers drug development and discovery services to pharmaceutical and biotech companies. The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetic and toxicokinetic studies. It offers services in the areas of pharmacology, toxicology, pathology, analytical chemistry, lab animal diagnostics, custom model generation, custom breeding, surgical models, and molecular biology.
63GF Score
Get the complete analysis for BOM:511509
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:511509 has been successfully added to your 
